Skip to main content
. 2021 Mar 29;8(4):43. doi: 10.3390/bioengineering8040043

Figure 5.

Figure 5

ROS responsiveness. (A) DLS of MMAF@BBN-PEG-PPADT before and after ROS exposure. (B) Drug-release behavior of MMAF@BBN-PEG-PPADT in PBS or under ROS.